FIELD: medicine.
SUBSTANCE: invention relates to field of medicine and deals with immunogenic composition. Essence of invention consists in development of immunogenic composition, obtained by culturing transformant of avirulent dividing yeasts-hosts Schizosaccharomyces pombe, in which transformant carries gen, which codes introduced into it antigen protein, representing capsid protein of L1 virus of human papilloma of 16 (HPV-16) type and accumulates in itself expressed antigen protein, for oral application.
EFFECT: development of immunogenic composition for oral application.
3 cl, 5 ex, 2 tbl, 5 dwg
| Title | Year | Author | Number |
|---|---|---|---|
| STABLE VECTOR OF CONSTITUTIVELY HIGH EXPRESSION FOR OBTAINING HPV VACCINE, AND RECOMBINANT LACTIC ACID BACTERIA TRANSFORMED BY THIS VECTOR | 2010 |
|
RU2492240C2 |
| MUCOSAL VACCINE FOR IMMUNE THERAPY OF DISEASES CAUSED BY HUMAN PAPILLOMA VIRUSES, AND RELATED THERAPY (VERSIONS) | 2008 |
|
RU2377305C1 |
| METHOD OF OBTAINING A RECOMBINANT VACCINE FOR PREVENTION OF HUMANPAPILLOMA VIRUS INFECTION, RECOMBINANT VACCINE | 2018 |
|
RU2681174C1 |
| RECOMBINANT VACCINE FOR PREVENTION OF HUMAN PAPILLOMAVIRUS INFECTION AND METHOD OF ITS PREPARATION | 2014 |
|
RU2546243C1 |
| RECOMBINANT STRAIN OF YEAST Hansenula polymorpha - PRODUCER OF MAJOR CAPSID PROTEIN L1 OF HUMAN PAPILLOMAVIRUS OF TYPE 16 | 2014 |
|
RU2546241C1 |
| POLYNUCLEOTIDE VACCINE FOR PAPILLOMA VIRUS | 1995 |
|
RU2173170C2 |
| PAPILLOMA VIRUS PURIFIED PROTEINS | 1995 |
|
RU2161651C2 |
| MUCOSAL INFLUENZA VIRUS VACCINE AND METHOD FOR INFLUENZA PREVENTION | 2004 |
|
RU2390351C2 |
| PICHIA ANGUSTA RECOMBINANT YEAST STRAIN - PRODUCER OF CAPSID PROTEIN L1 OF HUMAN PAPILLOMAVIRUS TYPE 16 | 2011 |
|
RU2445357C1 |
| RECOMBINANT PROTEIN CARRYING HUMAN PAPILLOMA VIRUS EPITOPES, PROTEIN EMBEDDED ADENYLATECYCLASE OR ITS FRAGMENT, ITS THERAPEUTIC APPLICATION | 2005 |
|
RU2441022C2 |
